Renal magnesium wasting, hypomagnesemic hypocalcemia, hypocalciuria and osteopenia in a patient with glycogenosis type II.
We describe a patient with late-onset glycogenosis type II with renal magnesium wasting, hypomagnesemic hypocalcemia, hypocalciuria and osteopenia. He was admitted to our hospital for evaluation of lower limb weakness and mild deterioration of liver function. Serum magnesium and calcium were low with low-to-normal levels of PTH in the patient. Echocardiogram revealed marked concentric hypertrophy of the left ventricle. An X-ray film of his spine showed a thoracic (Th12) vertebral compression fracture. Bone mineral density of the lumbar spine L2-L4 showed a reduced value. Kidney, liver and muscle biopsies were performed. These were found to have histologic features consistent with glycogenosis type II. In addition, accumulation of PAS-positive material in the cytoplasmic vacuoles of the tubular epithelium was present only in the distal tubules. An oral magnesium supplement was useful in helping to correct the hypomagnesemia, despite the presence of renal magnesium wasting in our patient. Magnesium supplement was also sufficient to maintain normal serum calcium concentrations. However, the hypocalciuria persisted in our patient despite correction of hypomagnesemia. In conclusion, the consistent association between the glycogen accumulation in distal tubules, renal magnesium wasting, hypomagnesemic hypocalcemia and hypocalciuria, in the absence of other identifiable reasons, suggests a cause-and-result relationship. Also, the combination of renal magnesium wasting, hypomagnesemia and hypocalciuria is a picture similar to that of Gitelman's syndrome in our patient. The glycogen accumulation in distal tubules may cause renal magnesium wasting and hypocalciuria through tubular injury. Therefore, we may speculate that the present case has glycogenosis type II-associated Gitelman's-like syndrome.
Oktenli
C
C
Department of Internal Medicine, Gülhane School of Medicine, Ankara, Turkey. c.oktenli@usa.net
D000328:Adult; D001851:Bone Diseases, Metabolic / Q000209:etiology*; D002118:Calcium / Q000652:urine*; D006009:Glycogen Storage Disease Type II / Q000150:complications* / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D006996:Hypocalcemia / Q000209:etiology*; D007668:Kidney / Q000378:metabolism* / Q000473:pathology; D008274:Magnesium / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use; D008297:Male; D016103:Spinal Fractures / Q000209:etiology; D013904:Thoracic Vertebrae / Q000293:injuries
D008274:Magnesium; D002118:Calcium